Bunge's stock dropped 8.4% on July 29, closing at $107.61. That move landed on top of a 12-month return of +40.3% and a recent six-month slip of -7.4% — a market vote on the same set of numbers investors are parsing for different reasons.
Start with the obvious: the valuation looks cheap. Bunge trades at a P/E of 7.2x, EV/sales of 1.0x, an earnings yield of +13.8% and a cash-flow yield of +20.4%. Enterprise value is $17.7B with market cap $16.2B and net debt of $1.5B.
Then the messier facts. Revenue fell 15.4% year over year in the latest annual period, even as margins moved higher and reported net margin expanded (long-case evidence notes a +4.9 percentage-point change). Operating cash flow covered net income at 1.47x — solid on a cash basis, but the P&L has been lumpy.
Management points to the Viterra deal and commodity volatility as major sources of that lumpiness:
> "The increase from June 30, 2025 was primarily due to the Acquisition of Viterra, as well as an increase in unrealized losses on derivative contracts as a result of volatile commodity prices and higher accrued dividends." (Bunge / 10-Q / 2026-07-29)
Read: the acquisition added scale, but accounting for derivatives tied to commodity swings produced big, sometimes unrealized, hits and gains. That makes headline income jump around even when underlying flows may be steadier.
Foreign-exchange moves also stamped the P&L:
> "The increase was primarily due to $746 million of Net income (loss) attributable to Bunge and $70 million of income in Other comprehensive income (loss) resulting from favorable foreign exchange translation adjustments." (Bunge / 10-Q / 2026-07-29)
Read: currency translation delivered a large, one-off boost to reported income — useful to the bottom line, but not the same as rising crop demand.
Debt and capital activity have been active, too:
> "The decrease was primarily attributable to a decrease in net cash proceeds from short and long-term debt of $3,637 driven by prior year borrowings in preparation to fund the Acquisition of Viterra as well as a current period repayment of senior notes due in April 2026, partially offset by proceeds from the issuance of the 2026 Senior Notes in the first quarter of 2026." (Bunge / 10-Q / 2026-07-29)
Read: the company shuffled debt around to fund deals and pay down notes. Net debt sits at $1.5B now, but financing activity has been a material part of recent cash flow headlines.
There are operating bright spots: wheat volumes and prices rose in parts of the business, and ocean freight had a strong Q2 after a weak Q1:
> "Volumes and prices in our global wheat and wheat milling businesses increased due to higher supply and demand across various regions." (Bunge / 10-Q / 2026-07-29)
Read: commodity-driven tails in certain businesses lifted results.
> "Additionally, the favorable results in our ocean freight business during the second quarter of 2026, as described above, were partially offset by the unfavorable results recognized during the first quarter of 2026." (Bunge / 10-Q / 2026-07-29)
Read: transportation results swung quarter-to-quarter.
There’s also an ongoing sale that requires regulatory sign-off:
> "Completion of the sale is subject to customary closing conditions, including regulatory approval, and it is expected to close in 2026." (Bunge / 10-Q / 2026-04-29)
Read: more moving parts that could change the balance sheet or earnings mix when they close.
So here’s the tension: on raw multiples and cash yields Bunge looks inexpensive; on headline revenue and recorded earnings the story is noisy — acquisition accounting, FX translation, derivatives and freight swings all make the profit line bounce. The market’s knee-jerk 8.4% drop priced that uncertainty into the stock on one trading day.
*Figures and quotations from Bunge 10-Q filings dated 2026-07-29 and 2026-04-29; market prices from the July 29, 2026 close.*